nodes	percent_of_prediction	percent_of_DWPC	metapath
Linezolid—MAOB—nerve—type 2 diabetes mellitus	0.0087	0.154	CbGeAlD
Linezolid—MAOA—nerve—type 2 diabetes mellitus	0.00743	0.131	CbGeAlD
Linezolid—MAOB—Alpha-synuclein signaling—GRK5—type 2 diabetes mellitus	0.00722	0.0419	CbGpPWpGaD
Linezolid—MAOA—Biogenic Amine Synthesis—GAD2—type 2 diabetes mellitus	0.00648	0.0376	CbGpPWpGaD
Linezolid—Rivaroxaban—CYP3A4—type 2 diabetes mellitus	0.00639	1	CrCbGaD
Linezolid—MAOB—Dopamine metabolism—SOD1—type 2 diabetes mellitus	0.00576	0.0334	CbGpPWpGaD
Linezolid—MAOA—Melatonin metabolism and effects—ECE1—type 2 diabetes mellitus	0.00536	0.0311	CbGpPWpGaD
Linezolid—MAOA—Serotonin Transporter Activity—NOS1—type 2 diabetes mellitus	0.00477	0.0276	CbGpPWpGaD
Linezolid—MAOB—Dopamine metabolism—PPP2CA—type 2 diabetes mellitus	0.00476	0.0276	CbGpPWpGaD
Linezolid—MAOA—Dopamine metabolism—SOD1—type 2 diabetes mellitus	0.00362	0.021	CbGpPWpGaD
Linezolid—MAOA—Norepinephrine Neurotransmitter Release Cycle—SNAP25—type 2 diabetes mellitus	0.00361	0.0209	CbGpPWpGaD
Linezolid—MAOA—islet of Langerhans—type 2 diabetes mellitus	0.0036	0.0635	CbGeAlD
Linezolid—MAOB—nephron tubule—type 2 diabetes mellitus	0.00339	0.0599	CbGeAlD
Linezolid—MAOA—retina—type 2 diabetes mellitus	0.00308	0.0543	CbGeAlD
Linezolid—MAOB—cardiovascular system—type 2 diabetes mellitus	0.00305	0.0538	CbGeAlD
Linezolid—MAOA—Dopamine metabolism—PPP2CA—type 2 diabetes mellitus	0.00299	0.0173	CbGpPWpGaD
Linezolid—MAOB—kidney—type 2 diabetes mellitus	0.00298	0.0526	CbGeAlD
Linezolid—MAOB—cortex of kidney—type 2 diabetes mellitus	0.00291	0.0513	CbGeAlD
Linezolid—MAOA—nephron tubule—type 2 diabetes mellitus	0.0029	0.0511	CbGeAlD
Linezolid—MAOA—SIDS Susceptibility Pathways—PHOX2A—type 2 diabetes mellitus	0.00286	0.0166	CbGpPWpGaD
Linezolid—MAOA—Neurotransmitter Release Cycle—GAD2—type 2 diabetes mellitus	0.00284	0.0165	CbGpPWpGaD
Linezolid—MAOB—adipose tissue—type 2 diabetes mellitus	0.00269	0.0474	CbGeAlD
Linezolid—MAOA—cardiovascular system—type 2 diabetes mellitus	0.0026	0.0459	CbGeAlD
Linezolid—MAOA—kidney—type 2 diabetes mellitus	0.00255	0.0449	CbGeAlD
Linezolid—MAOA—pancreas—type 2 diabetes mellitus	0.00253	0.0446	CbGeAlD
Linezolid—MAOB—Tryptophan metabolism—CYP2E1—type 2 diabetes mellitus	0.00248	0.0144	CbGpPWpGaD
Linezolid—MAOA—cortex of kidney—type 2 diabetes mellitus	0.00248	0.0437	CbGeAlD
Linezolid—MAOB—Tryptophan metabolism—CYP1A2—type 2 diabetes mellitus	0.00245	0.0142	CbGpPWpGaD
Linezolid—MAOB—Tryptophan metabolism—CYP3A4—type 2 diabetes mellitus	0.00239	0.0139	CbGpPWpGaD
Linezolid—MAOA—Oxidative Stress—CYBA—type 2 diabetes mellitus	0.00232	0.0135	CbGpPWpGaD
Linezolid—MAOA—adipose tissue—type 2 diabetes mellitus	0.00229	0.0405	CbGeAlD
Linezolid—MAOA—Melatonin metabolism and effects—CYP1A2—type 2 diabetes mellitus	0.00223	0.0129	CbGpPWpGaD
Linezolid—MAOB—Biological oxidations—MAT1A—type 2 diabetes mellitus	0.00213	0.0124	CbGpPWpGaD
Linezolid—MAOB—Tryptophan metabolism—CAT—type 2 diabetes mellitus	0.00199	0.0115	CbGpPWpGaD
Linezolid—MAOB—Phase 1 - Functionalization of compounds—CYP11A1—type 2 diabetes mellitus	0.00197	0.0114	CbGpPWpGaD
Linezolid—MAOB—liver—type 2 diabetes mellitus	0.00189	0.0333	CbGeAlD
Linezolid—MAOA—Oxidative Stress—SOD1—type 2 diabetes mellitus	0.00185	0.0107	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—NEUROD1—type 2 diabetes mellitus	0.00184	0.0107	CbGpPWpGaD
Linezolid—MAOA—Neurotransmitter Release Cycle—SNAP25—type 2 diabetes mellitus	0.00183	0.0106	CbGpPWpGaD
Linezolid—MAOA—Oxidative Stress—HMOX1—type 2 diabetes mellitus	0.00178	0.0103	CbGpPWpGaD
Linezolid—MAOA—Oxidative Stress—CAT—type 2 diabetes mellitus	0.00176	0.0102	CbGpPWpGaD
Linezolid—MAOA—Melatonin metabolism and effects—EDN1—type 2 diabetes mellitus	0.00173	0.01	CbGpPWpGaD
Linezolid—MAOA—Oxidative Stress—SOD2—type 2 diabetes mellitus	0.00167	0.00967	CbGpPWpGaD
Linezolid—MAOB—Phase 1 - Functionalization of compounds—CYP2E1—type 2 diabetes mellitus	0.00163	0.00943	CbGpPWpGaD
Linezolid—MAOA—liver—type 2 diabetes mellitus	0.00161	0.0284	CbGeAlD
Linezolid—MAOB—Phase 1 - Functionalization of compounds—CYP1A2—type 2 diabetes mellitus	0.00161	0.00933	CbGpPWpGaD
Linezolid—MAOA—Oxidative Stress—GPX1—type 2 diabetes mellitus	0.00159	0.00923	CbGpPWpGaD
Linezolid—MAOB—Phase 1 - Functionalization of compounds—CYP3A4—type 2 diabetes mellitus	0.00157	0.0091	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—KCNQ1—type 2 diabetes mellitus	0.0015	0.00871	CbGpPWpGaD
Linezolid—MAOA—Melatonin metabolism and effects—CALM1—type 2 diabetes mellitus	0.00141	0.00817	CbGpPWpGaD
Linezolid—MAOA—Melatonin metabolism and effects—APOE—type 2 diabetes mellitus	0.0014	0.00814	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—G6PC—type 2 diabetes mellitus	0.0014	0.00809	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—ECE1—type 2 diabetes mellitus	0.0014	0.00809	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—KCNK16—type 2 diabetes mellitus	0.00136	0.00789	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—MAT1A—type 2 diabetes mellitus	0.00134	0.00775	CbGpPWpGaD
Linezolid—MAOA—Phase 1 - Functionalization of compounds—CYP11A1—type 2 diabetes mellitus	0.00124	0.00717	CbGpPWpGaD
Linezolid—MAOB—Alpha-synuclein signaling—SRC—type 2 diabetes mellitus	0.00118	0.00682	CbGpPWpGaD
Linezolid—MAOB—Biological oxidations—MTR—type 2 diabetes mellitus	0.00108	0.00627	CbGpPWpGaD
Linezolid—MAOB—Biological oxidations—CYP11A1—type 2 diabetes mellitus	0.00105	0.00607	CbGpPWpGaD
Linezolid—MAOA—Phase 1 - Functionalization of compounds—CYP2E1—type 2 diabetes mellitus	0.00102	0.00592	CbGpPWpGaD
Linezolid—MAOA—Phase 1 - Functionalization of compounds—CYP1A2—type 2 diabetes mellitus	0.00101	0.00585	CbGpPWpGaD
Linezolid—MAOA—Phase 1 - Functionalization of compounds—CYP3A4—type 2 diabetes mellitus	0.000984	0.00571	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—KCNQ1—type 2 diabetes mellitus	0.000943	0.00547	CbGpPWpGaD
Linezolid—MAOB—Biological oxidations—CYP2E1—type 2 diabetes mellitus	0.000864	0.00501	CbGpPWpGaD
Linezolid—MAOB—Biological oxidations—CYP1A2—type 2 diabetes mellitus	0.000854	0.00495	CbGpPWpGaD
Linezolid—MAOA—Melatonin metabolism and effects—NFKB1—type 2 diabetes mellitus	0.000835	0.00484	CbGpPWpGaD
Linezolid—MAOB—Biological oxidations—CYP3A4—type 2 diabetes mellitus	0.000833	0.00483	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—GAD2—type 2 diabetes mellitus	0.000815	0.00473	CbGpPWpGaD
Linezolid—MAOA—Oxidative Stress—NFKB1—type 2 diabetes mellitus	0.000813	0.00471	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—CPT1A—type 2 diabetes mellitus	0.000733	0.00425	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—ABCC8—type 2 diabetes mellitus	0.000715	0.00414	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—GCK—type 2 diabetes mellitus	0.000715	0.00414	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—MTR—type 2 diabetes mellitus	0.000678	0.00393	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—CYP11A1—type 2 diabetes mellitus	0.000657	0.00381	CbGpPWpGaD
Linezolid—MAOB—Biological oxidations—GSTM1—type 2 diabetes mellitus	0.000655	0.0038	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—SNAP25—type 2 diabetes mellitus	0.000641	0.00372	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—GAD2—type 2 diabetes mellitus	0.000625	0.00362	CbGpPWpGaD
Linezolid—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000584	0.000763	CcSEcCtD
Linezolid—Dysgeusia—Irbesartan—type 2 diabetes mellitus	0.000583	0.000763	CcSEcCtD
Linezolid—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000577	0.000754	CcSEcCtD
Linezolid—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.000572	0.000749	CcSEcCtD
Linezolid—Dry mouth—Orlistat—type 2 diabetes mellitus	0.00057	0.000745	CcSEcCtD
Linezolid—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000569	0.000744	CcSEcCtD
Linezolid—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000567	0.000741	CcSEcCtD
Linezolid—Vomiting—Glipizide—type 2 diabetes mellitus	0.000566	0.000741	CcSEcCtD
Linezolid—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000565	0.000739	CcSEcCtD
Linezolid—MAOA—Neuronal System—KCNJ11—type 2 diabetes mellitus	0.000565	0.00328	CbGpPWpGaD
Linezolid—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000564	0.000738	CcSEcCtD
Linezolid—Rash—Glipizide—type 2 diabetes mellitus	0.000561	0.000734	CcSEcCtD
Linezolid—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000561	0.000734	CcSEcCtD
Linezolid—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000561	0.000734	CcSEcCtD
Linezolid—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.00056	0.000733	CcSEcCtD
Linezolid—Erythema—Losartan—type 2 diabetes mellitus	0.00056	0.000733	CcSEcCtD
Linezolid—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000559	0.000731	CcSEcCtD
Linezolid—Headache—Glipizide—type 2 diabetes mellitus	0.000558	0.00073	CcSEcCtD
Linezolid—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000557	0.000728	CcSEcCtD
Linezolid—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000554	0.000724	CcSEcCtD
Linezolid—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000553	0.000723	CcSEcCtD
Linezolid—Flatulence—Losartan—type 2 diabetes mellitus	0.000552	0.000722	CcSEcCtD
Linezolid—Anaemia—Irbesartan—type 2 diabetes mellitus	0.00055	0.00072	CcSEcCtD
Linezolid—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000549	0.000719	CcSEcCtD
Linezolid—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000549	0.000718	CcSEcCtD
Linezolid—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000549	0.000718	CcSEcCtD
Linezolid—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000549	0.000718	CcSEcCtD
Linezolid—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000548	0.000716	CcSEcCtD
Linezolid—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000547	0.000716	CcSEcCtD
Linezolid—Hypertension—Metformin—type 2 diabetes mellitus	0.000545	0.000712	CcSEcCtD
Linezolid—Urticaria—Glyburide—type 2 diabetes mellitus	0.000544	0.000712	CcSEcCtD
Linezolid—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000544	0.000711	CcSEcCtD
Linezolid—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000543	0.00071	CcSEcCtD
Linezolid—MAOA—Biological oxidations—CYP2E1—type 2 diabetes mellitus	0.000542	0.00314	CbGpPWpGaD
Linezolid—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000542	0.000709	CcSEcCtD
Linezolid—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000542	0.000708	CcSEcCtD
Linezolid—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.00054	0.000706	CcSEcCtD
Linezolid—Anorexia—Valsartan—type 2 diabetes mellitus	0.000539	0.000705	CcSEcCtD
Linezolid—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000539	0.000705	CcSEcCtD
Linezolid—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000538	0.000703	CcSEcCtD
Linezolid—MAOA—Biological oxidations—CYP1A2—type 2 diabetes mellitus	0.000536	0.00311	CbGpPWpGaD
Linezolid—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000535	0.0007	CcSEcCtD
Linezolid—Headache—Pioglitazone—type 2 diabetes mellitus	0.000534	0.000699	CcSEcCtD
Linezolid—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000533	0.000697	CcSEcCtD
Linezolid—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000531	0.000695	CcSEcCtD
Linezolid—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000531	0.000694	CcSEcCtD
Linezolid—Nausea—Glipizide—type 2 diabetes mellitus	0.000529	0.000692	CcSEcCtD
Linezolid—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000528	0.000691	CcSEcCtD
Linezolid—Vision blurred—Losartan—type 2 diabetes mellitus	0.000528	0.000691	CcSEcCtD
Linezolid—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000527	0.000689	CcSEcCtD
Linezolid—Constipation—Gliclazide—type 2 diabetes mellitus	0.000526	0.000688	CcSEcCtD
Linezolid—Pain—Gliclazide—type 2 diabetes mellitus	0.000526	0.000688	CcSEcCtD
Linezolid—MAOA—Transmission across Chemical Synapses—SNAP25—type 2 diabetes mellitus	0.000525	0.00305	CbGpPWpGaD
Linezolid—Rash—Glimepiride—type 2 diabetes mellitus	0.000524	0.000685	CcSEcCtD
Linezolid—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000523	0.000685	CcSEcCtD
Linezolid—MAOA—Biological oxidations—CYP3A4—type 2 diabetes mellitus	0.000523	0.00303	CbGpPWpGaD
Linezolid—Rash—Sitagliptin—type 2 diabetes mellitus	0.000522	0.000683	CcSEcCtD
Linezolid—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000522	0.000682	CcSEcCtD
Linezolid—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000522	0.000682	CcSEcCtD
Linezolid—Headache—Glimepiride—type 2 diabetes mellitus	0.000521	0.000681	CcSEcCtD
Linezolid—Cough—Irbesartan—type 2 diabetes mellitus	0.000519	0.000679	CcSEcCtD
Linezolid—Headache—Sitagliptin—type 2 diabetes mellitus	0.000519	0.000679	CcSEcCtD
Linezolid—Anaemia—Losartan—type 2 diabetes mellitus	0.000518	0.000677	CcSEcCtD
Linezolid—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000515	0.000673	CcSEcCtD
Linezolid—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000514	0.000672	CcSEcCtD
Linezolid—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000513	0.000671	CcSEcCtD
Linezolid—MAOA—SIDS Susceptibility Pathways—GJA1—type 2 diabetes mellitus	0.000512	0.00297	CbGpPWpGaD
Linezolid—Angioedema—Losartan—type 2 diabetes mellitus	0.000512	0.00067	CcSEcCtD
Linezolid—Insomnia—Valsartan—type 2 diabetes mellitus	0.000511	0.000669	CcSEcCtD
Linezolid—MAOA—SIDS Susceptibility Pathways—AR—type 2 diabetes mellitus	0.000508	0.00295	CbGpPWpGaD
Linezolid—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000508	0.000664	CcSEcCtD
Linezolid—Insomnia—Orlistat—type 2 diabetes mellitus	0.000505	0.000661	CcSEcCtD
Linezolid—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000504	0.000659	CcSEcCtD
Linezolid—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000504	0.000659	CcSEcCtD
Linezolid—Vertigo—Losartan—type 2 diabetes mellitus	0.000503	0.000658	CcSEcCtD
Linezolid—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000503	0.000658	CcSEcCtD
Linezolid—Somnolence—Valsartan—type 2 diabetes mellitus	0.000503	0.000657	CcSEcCtD
Linezolid—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000502	0.000656	CcSEcCtD
Linezolid—Leukopenia—Losartan—type 2 diabetes mellitus	0.000501	0.000656	CcSEcCtD
Linezolid—Skin disorder—Metformin—type 2 diabetes mellitus	0.0005	0.000654	CcSEcCtD
Linezolid—MAOB—Metabolism—BHMT—type 2 diabetes mellitus	0.000499	0.0029	CbGpPWpGaD
Linezolid—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000498	0.000651	CcSEcCtD
Linezolid—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000498	0.000651	CcSEcCtD
Linezolid—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000496	0.000648	CcSEcCtD
Linezolid—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000496	0.000648	CcSEcCtD
Linezolid—Nausea—Glimepiride—type 2 diabetes mellitus	0.000494	0.000646	CcSEcCtD
Linezolid—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000492	0.000644	CcSEcCtD
Linezolid—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000492	0.000643	CcSEcCtD
Linezolid—Asthenia—Glyburide—type 2 diabetes mellitus	0.000492	0.000643	CcSEcCtD
Linezolid—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000491	0.000643	CcSEcCtD
Linezolid—Anorexia—Metformin—type 2 diabetes mellitus	0.000491	0.000642	CcSEcCtD
Linezolid—Cough—Losartan—type 2 diabetes mellitus	0.000489	0.000639	CcSEcCtD
Linezolid—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000489	0.000639	CcSEcCtD
Linezolid—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000488	0.000638	CcSEcCtD
Linezolid—Fatigue—Valsartan—type 2 diabetes mellitus	0.000487	0.000638	CcSEcCtD
Linezolid—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000486	0.000636	CcSEcCtD
Linezolid—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000486	0.000636	CcSEcCtD
Linezolid—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000486	0.000635	CcSEcCtD
Linezolid—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000486	0.000635	CcSEcCtD
Linezolid—Pruritus—Glyburide—type 2 diabetes mellitus	0.000485	0.000634	CcSEcCtD
Linezolid—Constipation—Valsartan—type 2 diabetes mellitus	0.000483	0.000632	CcSEcCtD
Linezolid—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000482	0.000631	CcSEcCtD
Linezolid—Fatigue—Orlistat—type 2 diabetes mellitus	0.000482	0.00063	CcSEcCtD
Linezolid—Erythema—Ramipril—type 2 diabetes mellitus	0.00048	0.000628	CcSEcCtD
Linezolid—MAOA—SIDS Susceptibility Pathways—PPARGC1A—type 2 diabetes mellitus	0.000479	0.00278	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—GNB3—type 2 diabetes mellitus	0.000479	0.00278	CbGpPWpGaD
Linezolid—Pain—Orlistat—type 2 diabetes mellitus	0.000478	0.000625	CcSEcCtD
Linezolid—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000477	0.000623	CcSEcCtD
Linezolid—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000476	0.000622	CcSEcCtD
Linezolid—Rash—Bromocriptine—type 2 diabetes mellitus	0.000473	0.000618	CcSEcCtD
Linezolid—MAOA—SIDS Susceptibility Pathways—AVP—type 2 diabetes mellitus	0.000472	0.00274	CbGpPWpGaD
Linezolid—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000472	0.000618	CcSEcCtD
Linezolid—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000472	0.000617	CcSEcCtD
Linezolid—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.00047	0.000615	CcSEcCtD
Linezolid—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.00047	0.000614	CcSEcCtD
Linezolid—Headache—Bromocriptine—type 2 diabetes mellitus	0.00047	0.000614	CcSEcCtD
Linezolid—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000469	0.000613	CcSEcCtD
Linezolid—Dry mouth—Losartan—type 2 diabetes mellitus	0.000466	0.00061	CcSEcCtD
Linezolid—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000463	0.000606	CcSEcCtD
Linezolid—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000462	0.000605	CcSEcCtD
Linezolid—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000462	0.000605	CcSEcCtD
Linezolid—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000462	0.000604	CcSEcCtD
Linezolid—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000459	0.0006	CcSEcCtD
Linezolid—Somnolence—Metformin—type 2 diabetes mellitus	0.000458	0.000599	CcSEcCtD
Linezolid—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000457	0.000598	CcSEcCtD
Linezolid—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000457	0.000598	CcSEcCtD
Linezolid—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000453	0.000593	CcSEcCtD
Linezolid—Urticaria—Valsartan—type 2 diabetes mellitus	0.000449	0.000587	CcSEcCtD
Linezolid—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000448	0.000586	CcSEcCtD
Linezolid—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000448	0.000585	CcSEcCtD
Linezolid—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000447	0.000585	CcSEcCtD
Linezolid—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000445	0.000582	CcSEcCtD
Linezolid—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000444	0.000581	CcSEcCtD
Linezolid—Fatigue—Metformin—type 2 diabetes mellitus	0.000444	0.000581	CcSEcCtD
Linezolid—Urticaria—Orlistat—type 2 diabetes mellitus	0.000444	0.00058	CcSEcCtD
Linezolid—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000442	0.000578	CcSEcCtD
Linezolid—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000442	0.000578	CcSEcCtD
Linezolid—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000442	0.000578	CcSEcCtD
Linezolid—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000441	0.000577	CcSEcCtD
Linezolid—Constipation—Metformin—type 2 diabetes mellitus	0.00044	0.000576	CcSEcCtD
Linezolid—Angioedema—Ramipril—type 2 diabetes mellitus	0.000439	0.000574	CcSEcCtD
Linezolid—MAOB—Metabolism—AANAT—type 2 diabetes mellitus	0.000436	0.00253	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PTGDS—type 2 diabetes mellitus	0.000436	0.00253	CbGpPWpGaD
Linezolid—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000436	0.000571	CcSEcCtD
Linezolid—Anorexia—Losartan—type 2 diabetes mellitus	0.000436	0.00057	CcSEcCtD
Linezolid—Vomiting—Glyburide—type 2 diabetes mellitus	0.000436	0.00057	CcSEcCtD
Linezolid—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000435	0.000569	CcSEcCtD
Linezolid—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000433	0.000567	CcSEcCtD
Linezolid—Rash—Glyburide—type 2 diabetes mellitus	0.000432	0.000565	CcSEcCtD
Linezolid—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000432	0.000565	CcSEcCtD
Linezolid—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000432	0.000565	CcSEcCtD
Linezolid—Vertigo—Ramipril—type 2 diabetes mellitus	0.000432	0.000565	CcSEcCtD
Linezolid—Leukopenia—Ramipril—type 2 diabetes mellitus	0.00043	0.000562	CcSEcCtD
Linezolid—Headache—Glyburide—type 2 diabetes mellitus	0.000429	0.000562	CcSEcCtD
Linezolid—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000428	0.000559	CcSEcCtD
Linezolid—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000422	0.000552	CcSEcCtD
Linezolid—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000421	0.000551	CcSEcCtD
Linezolid—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000421	0.000551	CcSEcCtD
Linezolid—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000419	0.000549	CcSEcCtD
Linezolid—Cough—Ramipril—type 2 diabetes mellitus	0.000419	0.000548	CcSEcCtD
Linezolid—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000419	0.000548	CcSEcCtD
Linezolid—Convulsion—Ramipril—type 2 diabetes mellitus	0.000416	0.000544	CcSEcCtD
Linezolid—Pain—Irbesartan—type 2 diabetes mellitus	0.000415	0.000543	CcSEcCtD
Linezolid—Constipation—Irbesartan—type 2 diabetes mellitus	0.000415	0.000543	CcSEcCtD
Linezolid—MAOB—Metabolism—GPD2—type 2 diabetes mellitus	0.000414	0.0024	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CDO1—type 2 diabetes mellitus	0.000414	0.0024	CbGpPWpGaD
Linezolid—Insomnia—Losartan—type 2 diabetes mellitus	0.000414	0.000541	CcSEcCtD
Linezolid—MAOA—SIDS Susceptibility Pathways—NR3C1—type 2 diabetes mellitus	0.000411	0.00238	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—GSTM1—type 2 diabetes mellitus	0.000411	0.00238	CbGpPWpGaD
Linezolid—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000411	0.000537	CcSEcCtD
Linezolid—Urticaria—Metformin—type 2 diabetes mellitus	0.000409	0.000535	CcSEcCtD
Linezolid—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000408	0.000533	CcSEcCtD
Linezolid—Nausea—Glyburide—type 2 diabetes mellitus	0.000407	0.000532	CcSEcCtD
Linezolid—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000407	0.000532	CcSEcCtD
Linezolid—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000407	0.000532	CcSEcCtD
Linezolid—Somnolence—Losartan—type 2 diabetes mellitus	0.000406	0.000532	CcSEcCtD
Linezolid—Asthenia—Valsartan—type 2 diabetes mellitus	0.000406	0.000531	CcSEcCtD
Linezolid—MAOA—Neuronal System—SNAP25—type 2 diabetes mellitus	0.000403	0.00233	CbGpPWpGaD
Linezolid—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000402	0.000526	CcSEcCtD
Linezolid—Asthenia—Orlistat—type 2 diabetes mellitus	0.000401	0.000524	CcSEcCtD
Linezolid—Pruritus—Valsartan—type 2 diabetes mellitus	0.0004	0.000523	CcSEcCtD
Linezolid—Dry mouth—Ramipril—type 2 diabetes mellitus	0.0004	0.000523	CcSEcCtD
Linezolid—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000397	0.00052	CcSEcCtD
Linezolid—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000397	0.00052	CcSEcCtD
Linezolid—Pruritus—Orlistat—type 2 diabetes mellitus	0.000395	0.000517	CcSEcCtD
Linezolid—MAOB—Metabolism—AK1—type 2 diabetes mellitus	0.000395	0.00229	CbGpPWpGaD
Linezolid—Fatigue—Losartan—type 2 diabetes mellitus	0.000394	0.000516	CcSEcCtD
Linezolid—MAOA—Transmission across Chemical Synapses—GNB3—type 2 diabetes mellitus	0.000393	0.00228	CbGpPWpGaD
Linezolid—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000392	0.000513	CcSEcCtD
Linezolid—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000391	0.000512	CcSEcCtD
Linezolid—Constipation—Losartan—type 2 diabetes mellitus	0.000391	0.000511	CcSEcCtD
Linezolid—Pain—Losartan—type 2 diabetes mellitus	0.000391	0.000511	CcSEcCtD
Linezolid—Rash—Gliclazide—type 2 diabetes mellitus	0.000388	0.000507	CcSEcCtD
Linezolid—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000388	0.000507	CcSEcCtD
Linezolid—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000387	0.000506	CcSEcCtD
Linezolid—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000386	0.000505	CcSEcCtD
Linezolid—Headache—Gliclazide—type 2 diabetes mellitus	0.000385	0.000504	CcSEcCtD
Linezolid—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000384	0.000502	CcSEcCtD
Linezolid—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000384	0.000502	CcSEcCtD
Linezolid—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000384	0.000502	CcSEcCtD
Linezolid—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000382	0.0005	CcSEcCtD
Linezolid—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000381	0.000498	CcSEcCtD
Linezolid—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000379	0.000496	CcSEcCtD
Linezolid—MAOA—SIDS Susceptibility Pathways—HIF1A—type 2 diabetes mellitus	0.000374	0.00217	CbGpPWpGaD
Linezolid—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000374	0.000489	CcSEcCtD
Linezolid—Dizziness—Valsartan—type 2 diabetes mellitus	0.000374	0.000489	CcSEcCtD
Linezolid—Anorexia—Ramipril—type 2 diabetes mellitus	0.000374	0.000489	CcSEcCtD
Linezolid—Dizziness—Orlistat—type 2 diabetes mellitus	0.000369	0.000483	CcSEcCtD
Linezolid—Asthenia—Metformin—type 2 diabetes mellitus	0.000369	0.000483	CcSEcCtD
Linezolid—Nausea—Gliclazide—type 2 diabetes mellitus	0.000365	0.000478	CcSEcCtD
Linezolid—MAOB—Metabolism—MAT1A—type 2 diabetes mellitus	0.000364	0.00211	CbGpPWpGaD
Linezolid—MAOB—Metabolism—SLC5A4—type 2 diabetes mellitus	0.000364	0.00211	CbGpPWpGaD
Linezolid—Pruritus—Metformin—type 2 diabetes mellitus	0.000364	0.000476	CcSEcCtD
Linezolid—Urticaria—Losartan—type 2 diabetes mellitus	0.000363	0.000475	CcSEcCtD
Linezolid—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000361	0.000473	CcSEcCtD
Linezolid—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000361	0.000473	CcSEcCtD
Linezolid—Vomiting—Valsartan—type 2 diabetes mellitus	0.000359	0.00047	CcSEcCtD
Linezolid—Rash—Valsartan—type 2 diabetes mellitus	0.000356	0.000466	CcSEcCtD
Linezolid—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000356	0.000466	CcSEcCtD
Linezolid—Vomiting—Orlistat—type 2 diabetes mellitus	0.000355	0.000465	CcSEcCtD
Linezolid—Insomnia—Ramipril—type 2 diabetes mellitus	0.000355	0.000464	CcSEcCtD
Linezolid—Headache—Valsartan—type 2 diabetes mellitus	0.000354	0.000463	CcSEcCtD
Linezolid—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000352	0.000461	CcSEcCtD
Linezolid—Rash—Orlistat—type 2 diabetes mellitus	0.000352	0.000461	CcSEcCtD
Linezolid—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000352	0.00046	CcSEcCtD
Linezolid—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000352	0.00046	CcSEcCtD
Linezolid—MAOB—Metabolism—ENPP1—type 2 diabetes mellitus	0.000352	0.00204	CbGpPWpGaD
Linezolid—MAOB—Metabolism—HBA2—type 2 diabetes mellitus	0.000352	0.00204	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ND1—type 2 diabetes mellitus	0.000352	0.00204	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PPP1R3C—type 2 diabetes mellitus	0.000352	0.00204	CbGpPWpGaD
Linezolid—MAOB—Metabolism—G6PC—type 2 diabetes mellitus	0.000352	0.00204	CbGpPWpGaD
Linezolid—Headache—Orlistat—type 2 diabetes mellitus	0.00035	0.000458	CcSEcCtD
Linezolid—MAOA—Transmission across Chemical Synapses—ADCY5—type 2 diabetes mellitus	0.00035	0.00203	CbGpPWpGaD
Linezolid—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.00035	0.000457	CcSEcCtD
Linezolid—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000349	0.000456	CcSEcCtD
Linezolid—Somnolence—Ramipril—type 2 diabetes mellitus	0.000349	0.000456	CcSEcCtD
Linezolid—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000345	0.000451	CcSEcCtD
Linezolid—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000344	0.00045	CcSEcCtD
Linezolid—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000341	0.000446	CcSEcCtD
Linezolid—MAOB—Metabolism—GCGR—type 2 diabetes mellitus	0.000341	0.00198	CbGpPWpGaD
Linezolid—Dizziness—Metformin—type 2 diabetes mellitus	0.00034	0.000445	CcSEcCtD
Linezolid—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000338	0.000443	CcSEcCtD
Linezolid—Fatigue—Ramipril—type 2 diabetes mellitus	0.000338	0.000442	CcSEcCtD
Linezolid—Nausea—Valsartan—type 2 diabetes mellitus	0.000336	0.000439	CcSEcCtD
Linezolid—Constipation—Ramipril—type 2 diabetes mellitus	0.000335	0.000439	CcSEcCtD
Linezolid—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000332	0.000435	CcSEcCtD
Linezolid—Nausea—Orlistat—type 2 diabetes mellitus	0.000332	0.000434	CcSEcCtD
Linezolid—Asthenia—Losartan—type 2 diabetes mellitus	0.000328	0.000429	CcSEcCtD
Linezolid—Vomiting—Metformin—type 2 diabetes mellitus	0.000327	0.000428	CcSEcCtD
Linezolid—Rash—Metformin—type 2 diabetes mellitus	0.000325	0.000425	CcSEcCtD
Linezolid—Dermatitis—Metformin—type 2 diabetes mellitus	0.000324	0.000424	CcSEcCtD
Linezolid—Pruritus—Losartan—type 2 diabetes mellitus	0.000323	0.000423	CcSEcCtD
Linezolid—Headache—Metformin—type 2 diabetes mellitus	0.000323	0.000422	CcSEcCtD
Linezolid—MAOB—Metabolism—OXCT1—type 2 diabetes mellitus	0.000322	0.00187	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CYTB—type 2 diabetes mellitus	0.000322	0.00187	CbGpPWpGaD
Linezolid—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000321	0.00042	CcSEcCtD
Linezolid—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000321	0.000419	CcSEcCtD
Linezolid—MAOB—Metabolism—SRD5A1—type 2 diabetes mellitus	0.000314	0.00182	CbGpPWpGaD
Linezolid—MAOA—Metabolism—BHMT—type 2 diabetes mellitus	0.000313	0.00182	CbGpPWpGaD
Linezolid—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000313	0.000409	CcSEcCtD
Linezolid—Urticaria—Ramipril—type 2 diabetes mellitus	0.000311	0.000407	CcSEcCtD
Linezolid—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.00031	0.000405	CcSEcCtD
Linezolid—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.00031	0.000405	CcSEcCtD
Linezolid—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000309	0.000404	CcSEcCtD
Linezolid—Rash—Irbesartan—type 2 diabetes mellitus	0.000306	0.000401	CcSEcCtD
Linezolid—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000306	0.0004	CcSEcCtD
Linezolid—Nausea—Metformin—type 2 diabetes mellitus	0.000306	0.0004	CcSEcCtD
Linezolid—Headache—Irbesartan—type 2 diabetes mellitus	0.000304	0.000398	CcSEcCtD
Linezolid—Dizziness—Losartan—type 2 diabetes mellitus	0.000302	0.000395	CcSEcCtD
Linezolid—MAOA—Neuronal System—GNB3—type 2 diabetes mellitus	0.000301	0.00174	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—CALM1—type 2 diabetes mellitus	0.000301	0.00174	CbGpPWpGaD
Linezolid—MAOB—Metabolism—STAR—type 2 diabetes mellitus	0.000299	0.00173	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ACACA—type 2 diabetes mellitus	0.000299	0.00173	CbGpPWpGaD
Linezolid—MAOB—Metabolism—HSD17B3—type 2 diabetes mellitus	0.000299	0.00173	CbGpPWpGaD
Linezolid—Vomiting—Losartan—type 2 diabetes mellitus	0.000291	0.00038	CcSEcCtD
Linezolid—Nausea—Irbesartan—type 2 diabetes mellitus	0.000289	0.000377	CcSEcCtD
Linezolid—Rash—Losartan—type 2 diabetes mellitus	0.000288	0.000377	CcSEcCtD
Linezolid—Dermatitis—Losartan—type 2 diabetes mellitus	0.000288	0.000377	CcSEcCtD
Linezolid—MAOB—Metabolism—ABCC8—type 2 diabetes mellitus	0.000287	0.00166	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CBS—type 2 diabetes mellitus	0.000287	0.00166	CbGpPWpGaD
Linezolid—Headache—Losartan—type 2 diabetes mellitus	0.000286	0.000375	CcSEcCtD
Linezolid—MAOA—Transmission across Chemical Synapses—PRKCB—type 2 diabetes mellitus	0.000283	0.00164	CbGpPWpGaD
Linezolid—Asthenia—Ramipril—type 2 diabetes mellitus	0.000281	0.000368	CcSEcCtD
Linezolid—Pruritus—Ramipril—type 2 diabetes mellitus	0.000277	0.000363	CcSEcCtD
Linezolid—MAOB—Metabolism—COX2—type 2 diabetes mellitus	0.000276	0.0016	CbGpPWpGaD
Linezolid—MAOB—Metabolism—SLC5A2—type 2 diabetes mellitus	0.000276	0.0016	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PTGDS—type 2 diabetes mellitus	0.000274	0.00159	CbGpPWpGaD
Linezolid—MAOA—Metabolism—AANAT—type 2 diabetes mellitus	0.000274	0.00159	CbGpPWpGaD
Linezolid—Nausea—Losartan—type 2 diabetes mellitus	0.000272	0.000355	CcSEcCtD
Linezolid—MAOB—Metabolism—NCOA6—type 2 diabetes mellitus	0.000271	0.00157	CbGpPWpGaD
Linezolid—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000268	0.000351	CcSEcCtD
Linezolid—MAOA—Neuronal System—ADCY5—type 2 diabetes mellitus	0.000268	0.00155	CbGpPWpGaD
Linezolid—MAOB—Metabolism—UCP2—type 2 diabetes mellitus	0.000267	0.00155	CbGpPWpGaD
Linezolid—MAOB—Metabolism—UCP3—type 2 diabetes mellitus	0.000267	0.00155	CbGpPWpGaD
Linezolid—MAOB—Metabolism—HSD11B1—type 2 diabetes mellitus	0.000267	0.00155	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CDO1—type 2 diabetes mellitus	0.00026	0.00151	CbGpPWpGaD
Linezolid—MAOA—Metabolism—GPD2—type 2 diabetes mellitus	0.00026	0.00151	CbGpPWpGaD
Linezolid—Dizziness—Ramipril—type 2 diabetes mellitus	0.000259	0.000339	CcSEcCtD
Linezolid—MAOB—Metabolism—PCK1—type 2 diabetes mellitus	0.000251	0.00145	CbGpPWpGaD
Linezolid—Vomiting—Ramipril—type 2 diabetes mellitus	0.000249	0.000326	CcSEcCtD
Linezolid—MAOA—Metabolism—AK1—type 2 diabetes mellitus	0.000248	0.00144	CbGpPWpGaD
Linezolid—Rash—Ramipril—type 2 diabetes mellitus	0.000247	0.000323	CcSEcCtD
Linezolid—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000247	0.000323	CcSEcCtD
Linezolid—Headache—Ramipril—type 2 diabetes mellitus	0.000246	0.000321	CcSEcCtD
Linezolid—MAOB—Metabolism—HK1—type 2 diabetes mellitus	0.000235	0.00136	CbGpPWpGaD
Linezolid—Nausea—Ramipril—type 2 diabetes mellitus	0.000233	0.000305	CcSEcCtD
Linezolid—MAOA—SIDS Susceptibility Pathways—CASP3—type 2 diabetes mellitus	0.000232	0.00135	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—CALM1—type 2 diabetes mellitus	0.00023	0.00134	CbGpPWpGaD
Linezolid—MAOA—Metabolism—MAT1A—type 2 diabetes mellitus	0.000229	0.00133	CbGpPWpGaD
Linezolid—MAOA—Metabolism—SLC5A4—type 2 diabetes mellitus	0.000229	0.00133	CbGpPWpGaD
Linezolid—MAOB—Metabolism—LPA—type 2 diabetes mellitus	0.000227	0.00131	CbGpPWpGaD
Linezolid—MAOB—Metabolism—KCNJ11—type 2 diabetes mellitus	0.000227	0.00131	CbGpPWpGaD
Linezolid—MAOB—Metabolism—GCKR—type 2 diabetes mellitus	0.000227	0.00131	CbGpPWpGaD
Linezolid—MAOB—Metabolism—HSD3B2—type 2 diabetes mellitus	0.000227	0.00131	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ENPP1—type 2 diabetes mellitus	0.000221	0.00128	CbGpPWpGaD
Linezolid—MAOA—Metabolism—HBA2—type 2 diabetes mellitus	0.000221	0.00128	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ND1—type 2 diabetes mellitus	0.000221	0.00128	CbGpPWpGaD
Linezolid—MAOA—Metabolism—G6PC—type 2 diabetes mellitus	0.000221	0.00128	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PPP1R3C—type 2 diabetes mellitus	0.000221	0.00128	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ALDOB—type 2 diabetes mellitus	0.000217	0.00126	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—NFKB1—type 2 diabetes mellitus	0.000217	0.00126	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—PRKCB—type 2 diabetes mellitus	0.000216	0.00126	CbGpPWpGaD
Linezolid—MAOA—Metabolism—GCGR—type 2 diabetes mellitus	0.000214	0.00124	CbGpPWpGaD
Linezolid—MAOB—Metabolism—GLP1R—type 2 diabetes mellitus	0.000202	0.00117	CbGpPWpGaD
Linezolid—MAOA—Metabolism—OXCT1—type 2 diabetes mellitus	0.000202	0.00117	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CYTB—type 2 diabetes mellitus	0.000202	0.00117	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—VEGFA—type 2 diabetes mellitus	0.000197	0.00114	CbGpPWpGaD
Linezolid—MAOA—Metabolism—SRD5A1—type 2 diabetes mellitus	0.000197	0.00114	CbGpPWpGaD
Linezolid—MAOB—Metabolism—SLC2A2—type 2 diabetes mellitus	0.000189	0.00109	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ACACA—type 2 diabetes mellitus	0.000188	0.00109	CbGpPWpGaD
Linezolid—MAOA—Metabolism—HSD17B3—type 2 diabetes mellitus	0.000188	0.00109	CbGpPWpGaD
Linezolid—MAOA—Metabolism—STAR—type 2 diabetes mellitus	0.000188	0.00109	CbGpPWpGaD
Linezolid—MAOB—Metabolism—MTR—type 2 diabetes mellitus	0.000185	0.00107	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CPT1A—type 2 diabetes mellitus	0.000185	0.00107	CbGpPWpGaD
Linezolid—MAOB—Metabolism—NAMPT—type 2 diabetes mellitus	0.000181	0.00105	CbGpPWpGaD
Linezolid—MAOB—Metabolism—HBA1—type 2 diabetes mellitus	0.00018	0.00104	CbGpPWpGaD
Linezolid—MAOB—Metabolism—LIPC—type 2 diabetes mellitus	0.00018	0.00104	CbGpPWpGaD
Linezolid—MAOB—Metabolism—GCK—type 2 diabetes mellitus	0.00018	0.00104	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ABCC8—type 2 diabetes mellitus	0.00018	0.00104	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CBS—type 2 diabetes mellitus	0.00018	0.00104	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CYP11A1—type 2 diabetes mellitus	0.000179	0.00104	CbGpPWpGaD
Linezolid—MAOB—Metabolism—SLC9A1—type 2 diabetes mellitus	0.000176	0.00102	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CETP—type 2 diabetes mellitus	0.000174	0.00101	CbGpPWpGaD
Linezolid—MAOA—Metabolism—SLC5A2—type 2 diabetes mellitus	0.000173	0.001	CbGpPWpGaD
Linezolid—MAOA—Metabolism—COX2—type 2 diabetes mellitus	0.000173	0.001	CbGpPWpGaD
Linezolid—MAOA—Metabolism—NCOA6—type 2 diabetes mellitus	0.00017	0.000987	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—TNF—type 2 diabetes mellitus	0.000169	0.000981	CbGpPWpGaD
Linezolid—MAOA—Metabolism—UCP3—type 2 diabetes mellitus	0.000167	0.00097	CbGpPWpGaD
Linezolid—MAOA—Metabolism—UCP2—type 2 diabetes mellitus	0.000167	0.00097	CbGpPWpGaD
Linezolid—MAOA—Metabolism—HSD11B1—type 2 diabetes mellitus	0.000167	0.00097	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PSMD6—type 2 diabetes mellitus	0.000162	0.000937	CbGpPWpGaD
Linezolid—MAOB—Metabolism—SREBF1—type 2 diabetes mellitus	0.000162	0.000937	CbGpPWpGaD
Linezolid—MAOB—Metabolism—SNAP25—type 2 diabetes mellitus	0.000162	0.000937	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CTGF—type 2 diabetes mellitus	0.000159	0.00092	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PCK1—type 2 diabetes mellitus	0.000157	0.000912	CbGpPWpGaD
Linezolid—MAOB—Metabolism—HMGCR—type 2 diabetes mellitus	0.000157	0.000911	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ADRA2A—type 2 diabetes mellitus	0.000154	0.000892	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CYP2E1—type 2 diabetes mellitus	0.000148	0.000857	CbGpPWpGaD
Linezolid—MAOA—Metabolism—HK1—type 2 diabetes mellitus	0.000147	0.000854	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CYP1A2—type 2 diabetes mellitus	0.000146	0.000847	CbGpPWpGaD
Linezolid—MAOB—Metabolism—SLC2A1—type 2 diabetes mellitus	0.000146	0.000847	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CYP3A4—type 2 diabetes mellitus	0.000142	0.000826	CbGpPWpGaD
Linezolid—MAOA—Metabolism—GCKR—type 2 diabetes mellitus	0.000142	0.000825	CbGpPWpGaD
Linezolid—MAOA—Metabolism—KCNJ11—type 2 diabetes mellitus	0.000142	0.000825	CbGpPWpGaD
Linezolid—MAOA—Metabolism—HSD3B2—type 2 diabetes mellitus	0.000142	0.000825	CbGpPWpGaD
Linezolid—MAOA—Metabolism—LPA—type 2 diabetes mellitus	0.000142	0.000825	CbGpPWpGaD
Linezolid—MAOB—Metabolism—GCG—type 2 diabetes mellitus	0.00014	0.000812	CbGpPWpGaD
Linezolid—MAOB—Metabolism—SLC2A4—type 2 diabetes mellitus	0.00014	0.000812	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	0.000136	0.000791	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ALDOB—type 2 diabetes mellitus	0.000136	0.000791	CbGpPWpGaD
Linezolid—MAOA—Metabolism—GLP1R—type 2 diabetes mellitus	0.000127	0.000735	CbGpPWpGaD
Linezolid—MAOB—Metabolism—GNB3—type 2 diabetes mellitus	0.000121	0.0007	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PPARGC1A—type 2 diabetes mellitus	0.000121	0.0007	CbGpPWpGaD
Linezolid—MAOB—Metabolism—HMOX1—type 2 diabetes mellitus	0.00012	0.000697	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CAT—type 2 diabetes mellitus	0.000119	0.000688	CbGpPWpGaD
Linezolid—MAOA—Metabolism—SLC2A2—type 2 diabetes mellitus	0.000118	0.000687	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CPT1A—type 2 diabetes mellitus	0.000116	0.000673	CbGpPWpGaD
Linezolid—MAOA—Metabolism—MTR—type 2 diabetes mellitus	0.000116	0.000673	CbGpPWpGaD
Linezolid—MAOB—Metabolism—APOB—type 2 diabetes mellitus	0.000115	0.000668	CbGpPWpGaD
Linezolid—MAOA—Metabolism—NAMPT—type 2 diabetes mellitus	0.000114	0.00066	CbGpPWpGaD
Linezolid—MAOA—Metabolism—LIPC—type 2 diabetes mellitus	0.000113	0.000655	CbGpPWpGaD
Linezolid—MAOA—Metabolism—GCK—type 2 diabetes mellitus	0.000113	0.000655	CbGpPWpGaD
Linezolid—MAOA—Metabolism—HBA1—type 2 diabetes mellitus	0.000113	0.000655	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CYP11A1—type 2 diabetes mellitus	0.000112	0.000651	CbGpPWpGaD
Linezolid—MAOB—Metabolism—GSTM1—type 2 diabetes mellitus	0.000112	0.000649	CbGpPWpGaD
Linezolid—MAOA—Metabolism—SLC9A1—type 2 diabetes mellitus	0.00011	0.00064	CbGpPWpGaD
Linezolid—MAOB—Metabolism—LPL—type 2 diabetes mellitus	0.00011	0.000637	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CETP—type 2 diabetes mellitus	0.000109	0.000632	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ADCY5—type 2 diabetes mellitus	0.000108	0.000624	CbGpPWpGaD
Linezolid—MAOB—Metabolism—GPX1—type 2 diabetes mellitus	0.000107	0.000622	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CD36—type 2 diabetes mellitus	0.000104	0.000606	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PPP2CA—type 2 diabetes mellitus	0.000103	0.000598	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PSMD6—type 2 diabetes mellitus	0.000101	0.000588	CbGpPWpGaD
Linezolid—MAOA—Metabolism—SNAP25—type 2 diabetes mellitus	0.000101	0.000588	CbGpPWpGaD
Linezolid—MAOA—Metabolism—SREBF1—type 2 diabetes mellitus	0.000101	0.000588	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CTGF—type 2 diabetes mellitus	9.95e-05	0.000577	CbGpPWpGaD
Linezolid—MAOB—Metabolism—MTHFR—type 2 diabetes mellitus	9.9e-05	0.000574	CbGpPWpGaD
Linezolid—MAOA—Metabolism—HMGCR—type 2 diabetes mellitus	9.86e-05	0.000572	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PPARA—type 2 diabetes mellitus	9.71e-05	0.000563	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ADRA2A—type 2 diabetes mellitus	9.65e-05	0.00056	CbGpPWpGaD
Linezolid—MAOB—Metabolism—AGT—type 2 diabetes mellitus	9.4e-05	0.000545	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CYP2E1—type 2 diabetes mellitus	9.27e-05	0.000538	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CALM1—type 2 diabetes mellitus	9.25e-05	0.000536	CbGpPWpGaD
Linezolid—MAOB—Metabolism—APOE—type 2 diabetes mellitus	9.21e-05	0.000534	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CYP1A2—type 2 diabetes mellitus	9.17e-05	0.000532	CbGpPWpGaD
Linezolid—MAOA—Metabolism—SLC2A1—type 2 diabetes mellitus	9.17e-05	0.000532	CbGpPWpGaD
Linezolid—MAOB—Metabolism—APOA1—type 2 diabetes mellitus	9.11e-05	0.000528	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CYP3A4—type 2 diabetes mellitus	8.94e-05	0.000518	CbGpPWpGaD
Linezolid—MAOA—Metabolism—GCG—type 2 diabetes mellitus	8.79e-05	0.00051	CbGpPWpGaD
Linezolid—MAOA—Metabolism—SLC2A4—type 2 diabetes mellitus	8.79e-05	0.00051	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PPARG—type 2 diabetes mellitus	8.02e-05	0.000465	CbGpPWpGaD
Linezolid—MAOB—Metabolism—INS—type 2 diabetes mellitus	7.87e-05	0.000456	CbGpPWpGaD
Linezolid—MAOA—Metabolism—GNB3—type 2 diabetes mellitus	7.57e-05	0.000439	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.57e-05	0.000439	CbGpPWpGaD
Linezolid—MAOA—Metabolism—HMOX1—type 2 diabetes mellitus	7.54e-05	0.000437	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CAT—type 2 diabetes mellitus	7.44e-05	0.000431	CbGpPWpGaD
Linezolid—MAOA—Metabolism—APOB—type 2 diabetes mellitus	7.22e-05	0.000419	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ALB—type 2 diabetes mellitus	7.22e-05	0.000418	CbGpPWpGaD
Linezolid—MAOA—Metabolism—GSTM1—type 2 diabetes mellitus	7.03e-05	0.000407	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PIK3R1—type 2 diabetes mellitus	6.9e-05	0.0004	CbGpPWpGaD
Linezolid—MAOB—Metabolism—NOS3—type 2 diabetes mellitus	6.9e-05	0.0004	CbGpPWpGaD
Linezolid—MAOA—Metabolism—LPL—type 2 diabetes mellitus	6.9e-05	0.0004	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ADCY5—type 2 diabetes mellitus	6.75e-05	0.000392	CbGpPWpGaD
Linezolid—MAOA—Metabolism—GPX1—type 2 diabetes mellitus	6.73e-05	0.00039	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CD36—type 2 diabetes mellitus	6.55e-05	0.00038	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PPP2CA—type 2 diabetes mellitus	6.47e-05	0.000375	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PTGS2—type 2 diabetes mellitus	6.31e-05	0.000366	CbGpPWpGaD
Linezolid—MAOA—Metabolism—MTHFR—type 2 diabetes mellitus	6.21e-05	0.00036	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PPARA—type 2 diabetes mellitus	6.09e-05	0.000353	CbGpPWpGaD
Linezolid—MAOA—Metabolism—AGT—type 2 diabetes mellitus	5.9e-05	0.000342	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CALM1—type 2 diabetes mellitus	5.8e-05	0.000336	CbGpPWpGaD
Linezolid—MAOA—Metabolism—APOE—type 2 diabetes mellitus	5.78e-05	0.000335	CbGpPWpGaD
Linezolid—MAOA—Metabolism—APOA1—type 2 diabetes mellitus	5.71e-05	0.000331	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PPARG—type 2 diabetes mellitus	5.04e-05	0.000292	CbGpPWpGaD
Linezolid—MAOA—Metabolism—INS—type 2 diabetes mellitus	4.94e-05	0.000286	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ALB—type 2 diabetes mellitus	4.53e-05	0.000263	CbGpPWpGaD
Linezolid—MAOA—Metabolism—NOS3—type 2 diabetes mellitus	4.33e-05	0.000251	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PIK3R1—type 2 diabetes mellitus	4.33e-05	0.000251	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PTGS2—type 2 diabetes mellitus	3.96e-05	0.00023	CbGpPWpGaD
Linezolid—MAOB—Metabolism—AKT1—type 2 diabetes mellitus	3.17e-05	0.000184	CbGpPWpGaD
Linezolid—MAOA—Metabolism—AKT1—type 2 diabetes mellitus	1.99e-05	0.000115	CbGpPWpGaD
